ZEPP
Income statement / Annual
Last year (2024), Zepp Health Corporation's total revenue was $1.33 B,
a decrease of 46.61% from the previous year.
In 2024, Zepp Health Corporation's net income was -$554.13 M.
See Zepp Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.33 B |
$2.50 B |
$4.22 B |
$6.17 B |
$6.08 B |
$5.80 B |
$3.79 B |
$2.00 B |
$1.63 B |
$925.38 M |
| Cost of Revenue |
$820.57 M
|
$1.84 B
|
$3.40 B
|
$4.88 B
|
$4.82 B
|
$4.33 B
|
$2.81 B
|
$1.52 B
|
$1.34 B
|
$811.23 M
|
| Gross Profit |
$512.88 M
|
$653.70 M
|
$817.22 M
|
$1.29 B
|
$1.26 B
|
$1.46 B
|
$976.09 M
|
$482.26 M
|
$288.86 M
|
$114.16 M
|
| Gross Profit Ratio |
0.38
|
0.26
|
0.19
|
0.21
|
0.21
|
0.25
|
0.26
|
0.24
|
0.18
|
0.12
|
| Research and Development Expenses |
$337.07 M
|
$364.53 M
|
$526.20 M
|
$508.41 M
|
$508.64 M
|
$429.66 M
|
$273.49 M
|
$149.96 M
|
$138.39 M
|
$63.54 M
|
| General & Administrative Expenses |
$181.41 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$339.19 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$520.85 M
|
$504.69 M
|
$708.46 M
|
$687.60 M
|
$586.59 M
|
$415.08 M
|
$322.61 M
|
$154.91 M
|
$136.47 M
|
$92.03 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$857.92 M
|
$869.22 M
|
$1.23 B
|
$1.20 B
|
$1.10 B
|
$844.74 M
|
$596.10 M
|
$304.87 M
|
$274.86 M
|
$155.57 M
|
| Cost And Expenses |
$1.68 B
|
$2.71 B
|
$4.63 B
|
$6.08 B
|
$5.92 B
|
$5.18 B
|
$3.41 B
|
$1.82 B
|
$1.61 B
|
$966.79 M
|
| Interest Income |
$26.81 M
|
$21.86 M
|
$12.55 M
|
$16.47 M
|
$43.60 M
|
$33.39 M
|
$12.05 M
|
$2.93 M
|
$788.69 K
|
$263.23 K
|
| Interest Expense |
$40.54 M
|
$47.79 M
|
$58.00 M
|
$44.30 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$36.64 M
|
$54.43 M
|
$59.65 M
|
$51.21 M
|
$25.65 M
|
$17.17 M
|
$6.46 M
|
$3.62 M
|
$2.51 M
|
$294.19 K
|
| EBITDA |
-$345.66 M |
-$142.88 M |
-$261.43 M |
$200.80 M |
$276.76 M |
$667.78 M |
$408.15 M |
$190.70 M |
$32.70 M |
-$39.71 M |
| EBITDA Ratio |
-0.26
|
-0.06
|
-0.06
|
0.03
|
0.05
|
0.12
|
0.11
|
0.1
|
0.02
|
-0.04
|
| Operating Income Ratio |
-0.26
|
-0.09
|
-0.1
|
0.02
|
0.03
|
0.11
|
0.1
|
0.09
|
0.01
|
-0.04
|
| Total Other Income/Expenses Net |
-$108.55 M
|
-$21.70 M
|
$56.34 M
|
$53.06 M
|
$81.93 M
|
$30.46 M
|
$23.51 M
|
$12.42 M
|
$14.28 M
|
$1.41 M
|
| Income Before Tax |
-$453.59 M
|
-$237.22 M
|
-$361.11 M
|
$145.78 M
|
$246.62 M
|
$649.50 M
|
$403.50 M
|
$189.81 M
|
$28.28 M
|
-$40.00 M
|
| Income Before Tax Ratio |
-0.34
|
-0.09
|
-0.09
|
0.02
|
0.04
|
0.11
|
0.11
|
0.1
|
0.02
|
-0.04
|
| Income Tax Expense |
$99.99 M
|
-$17.20 M
|
-$67.03 M
|
$10.61 M
|
$29.45 M
|
$77.68 M
|
$54.07 M
|
$26.92 M
|
$3.23 M
|
-$925.94 K
|
| Net Income |
-$554.13 M
|
-$220.49 M
|
-$293.37 M
|
$136.02 M
|
$216.27 M
|
$573.64 M
|
$353.31 M
|
$163.46 M
|
$25.05 M
|
-$39.07 M
|
| Net Income Ratio |
-0.42
|
-0.09
|
-0.07
|
0.02
|
0.04
|
0.1
|
0.09
|
0.08
|
0.02
|
-0.04
|
| EPS |
-136.64 |
-7.84 |
-10.84 |
5.52 |
9 |
150.44 |
34.28 |
2.72 |
-13.96 |
-78.36 |
| EPS Diluted |
-136.64 |
-7.84 |
-10.84 |
5.24 |
8.64 |
143.36 |
32.48 |
2.6 |
-14.08 |
-78.36 |
| Weighted Average Shares Out |
$4.05 M
|
$3.80 M
|
$3.85 M
|
$3.94 M
|
$3.88 M
|
$3.85 M
|
$3.50 M
|
$3.71 M
|
$3.71 M
|
$3.71 M
|
| Weighted Average Shares Out Diluted |
$4.05 M
|
$3.80 M
|
$3.85 M
|
$4.13 M
|
$4.07 M
|
$4.04 M
|
$3.52 M
|
$3.71 M
|
$3.71 M
|
$3.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
